Mayo Clinic Researchers Report Breakthrough in Stiff-Person Syndrome Therapy
Mayo Clinic researchers report a promising breakthrough in treating Stiff-Person Syndrome using CAR-T cell therapy, allowing severely disabled patients to regain mobility and return to active lives.
A potential breakthrough in treating Stiff-Person Syndrome (SPS), a rare autoimmune disorder famously affecting singer Celine Dion, has been reported by researchers at the Mayo Clinic in the United States. Following an innovative immunotherapy trial utilizing CAR-T cell therapy, patients who previously struggled with basic daily activities and mobility experienced a dramatic recovery, returning to work, hobbies, and independent living.
Stiff-Person Syndrome attacks the central nervous system, causing severe, debilitating muscle rigidity and painful spasms. For decades, effective treatments have remained elusive. The experimental approach adapts CAR-T therapy, a treatment already established in oncology, by genetically reprogramming a patient's own immune cells to eliminate disease-driving cells. In this trial, physicians extracted T-cells from patients and re-engineered them to target and destroy the malfunctioning immune components.
Dramatic Patient Recovery and Clinical Findings
Dr. Anastasia Zekeridou, a neurologist and researcher at the Mayo Clinic, emphasized that the most striking aspect of the trial was the profound degree of recovery observed in several participants. The findings, published in the medical journal JAMA Neurology, demonstrate that unlike conventional therapies that merely manage symptoms, this novel approach has enabled patients to resume activities they feared were lost forever. Researchers are now focused on determining whether these positive results will endure over the long term.
Jonathan Walden, a trial participant who previously relied heavily on family members for basic assistance, reported complete cessation of muscle spasms since undergoing the procedure. "I can go to work every day, I can do everything I did before. I go hunting, I can go fishing," Walden stated. Another participant, Sherri St. Germain, suffered from severe leg cramps, muscle stiffness, and frequent falls. Following the treatment, she successfully walked on a treadmill for seven minutes consecutively and noted that she feels progressively better each day.
Broader Implications for Neurological Disorders
Dr. Sean Pittock, chair of neurology at the Mayo Clinic, noted that while CAR-T therapy has already revolutionized oncology, its successful application in autoimmune neurological conditions marks a significant milestone. He added that these outcomes offer immense hope for SPS sufferers and point toward a promising future for patients battling other immune-mediated neurological diseases who currently face limited therapeutic options.
In December 2022, renowned singer Celine Dion publicly announced her diagnosis with the syndrome, sharing in an emotional video that the condition severely impacted her life and her ability to perform. Meanwhile, Yasmin Sheikh, head of public policy at the blood cancer charity Anthony Nolan, who was not involved in the study, welcomed the development, emphasizing that the research provides compelling evidence that immunotherapy may offer transformative applications far beyond oncology.
